871038-72-1 structure, C20H20FKN6O5
Raltegravir potassium
CAS No.: 871038-72-1 Formula: C20H20FKN6O5 Molecular Weight: 482.50700
Search Suppliers

Raltegravir potassium

CAS No.:

871038-72-1

Formula:

C20H20FKN6O5

Molecular Weight: 482.50700
Suppliers: All (84) China Suppliers (55) Price Available (11) Contractor (5)

Description

Raltegravir (RAL, Isentress, formerly MK-0518) is an antiretroviral drug produced by Merck & Co., used to treat HIV infection. It received approval by the U.S. Food and Drug Administration (FDA) on 12 October 2007, the first of a new class of HIV drugs, the integrase inhibitors, to receive such approval.
In December 2011, it received FDA approval for pediatric use in patients ages 2–18, taken in pill form orally twice a day by prescription with two other antiretroviral medications to form the cocktail (most anti-HIV drugs regimens for adults and children use these cocktails). Raltegravir is available in chewable form, but because the two tablet formulations are not interchangeable, the chewable pills are only approved for use in children two to 11. Older adolescents will use the adult formulation.

Numbering system

UNII 43Y000U234

Properties

Appearance & Physical State

Off-white solid

Density

1.46 g/cm3

Melting Point

282ºC

Storage Condition

-20ºC Freezer

Safety Info

HS Code

2934999090
Recommended Suppliers
More Suppliers>>
Other items you might be interested in
Category in MOLBASE